6609 Stock Overview
Researches, develops, manufacture, and sells neuro-interventional medical devices in Mainland China.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 5/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Shanghai HeartCare Medical Technology Corporation Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | HK$15.20 |
52 Week High | HK$29.80 |
52 Week Low | HK$15.00 |
Beta | 0.79 |
11 Month Change | -1.68% |
3 Month Change | -21.49% |
1 Year Change | -47.22% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -88.22% |
Recent News & Updates
Some Shareholders Feeling Restless Over Shanghai HeartCare Medical Technology Corporation Limited's (HKG:6609) P/S Ratio
Aug 01We're Not Very Worried About Shanghai HeartCare Medical Technology's (HKG:6609) Cash Burn Rate
Jan 23Recent updates
Some Shareholders Feeling Restless Over Shanghai HeartCare Medical Technology Corporation Limited's (HKG:6609) P/S Ratio
Aug 01We're Not Very Worried About Shanghai HeartCare Medical Technology's (HKG:6609) Cash Burn Rate
Jan 23Shanghai HeartCare Medical Technology Corporation Limited (HKG:6609) Shares May Have Slumped 27% But Getting In Cheap Is Still Unlikely
Aug 30Companies Like Shanghai HeartCare Medical Technology (HKG:6609) Are In A Position To Invest In Growth
Aug 09Companies Like Shanghai HeartCare Medical Technology (HKG:6609) Are In A Position To Invest In Growth
May 07We're Hopeful That Shanghai HeartCare Medical Technology (HKG:6609) Will Use Its Cash Wisely
Nov 29Shareholder Returns
6609 | HK Medical Equipment | HK Market | |
---|---|---|---|
7D | -10.6% | -0.08% | -2.0% |
1Y | -47.2% | -47.7% | -4.9% |
Return vs Industry: 6609 matched the Hong Kong Medical Equipment industry which returned -47.7% over the past year.
Return vs Market: 6609 underperformed the Hong Kong Market which returned -4.9% over the past year.
Price Volatility
6609 volatility | |
---|---|
6609 Average Weekly Movement | 7.0% |
Medical Equipment Industry Average Movement | 7.1% |
Market Average Movement | 6.6% |
10% most volatile stocks in HK Market | 13.7% |
10% least volatile stocks in HK Market | 3.6% |
Stable Share Price: 6609's share price has been volatile over the past 3 months.
Volatility Over Time: 6609's weekly volatility (7%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2016 | 368 | Guohui Wang | www.heartcare.com.cn |
Shanghai HeartCare Medical Technology Corporation Limited researches, develops, manufacture, and sells neuro-interventional medical devices in Mainland China. The company offers ischemic stroke thrombectomy devices, such as Captor thrombectomy device, and aspiration catheter and pump; intracranial stenosis treatment devices comprising intracranial drug-eluting balloon catheter and embolization protection system; hemorrhagic stroke treatment devices, including coil embolization assistant stent and flow diverter device; and ischemic stroke prevention devices, such as LAA occlude. It also provides vascular access devices comprising distal access catheter, microcatheter, balloon guiding catheter, vascular closure device, support catheter, neuro-interventional microcatheter, micro guidewire, microcatheter for coiling, microcatheter for flow diverter device, and navigation catheter.
Shanghai HeartCare Medical Technology Corporation Limited Fundamentals Summary
6609 fundamental statistics | |
---|---|
Market cap | HK$579.75m |
Earnings (TTM) | -HK$102.14m |
Revenue (TTM) | HK$252.42m |
2.3x
P/S Ratio-5.7x
P/E RatioIs 6609 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
6609 income statement (TTM) | |
---|---|
Revenue | CN¥232.34m |
Cost of Revenue | CN¥80.55m |
Gross Profit | CN¥151.79m |
Other Expenses | CN¥245.81m |
Earnings | -CN¥94.01m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -2.46 |
Gross Margin | 65.33% |
Net Profit Margin | -40.46% |
Debt/Equity Ratio | 0% |
How did 6609 perform over the long term?
See historical performance and comparison